Quest Diagnostics (DGX) Operating Expenses (2009 - 2026)

Quest Diagnostics has disclosed Operating Expenses across 18 years of filings, most recently posting $2.5 billion for Q1 2026.

• Operating Expenses for Q1 2026 came in at $2.5 billion, up 8.24% year-over-year; the trailing twelve-month figure through Mar 2026 was $9.7 billion (up 10.3% YoY), and the FY2025 annual result was $9.5 billion, up 11.18% from the prior year.
• Operating Expenses came in at $2.5 billion for Q1 2026 at Quest Diagnostics, up from $2.4 billion in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $2.5 billion in Q1 2026 to a low of $2.0 billion in Q3 2023.
• The 5-year median for Operating Expenses is $2.1 billion (2022), against an average of $2.2 billion.
• Across the five-year window, Operating Expenses retreated 8.05% in 2023 and climbed 13.76% in 2025, its largest moves.
• Quest Diagnostics' Operating Expenses stood at $2.2 billion in 2022, then dropped by 8.05% to $2.0 billion in 2023, then gained by 11.83% to $2.3 billion in 2024, then grew by 7.08% to $2.4 billion in 2025, then increased by 3.14% to $2.5 billion in 2026.
• The last three Operating Expenses figures came in at $2.5 billion (Q1 2026), $2.4 billion (Q4 2025), and $2.4 billion (Q3 2025), per Business Quant data.